Calcium d-Glucarate
A calcium salt of D-glucaric acid marketed for 'estrogen detoxification' and cancer prevention. The mechanism (gut beta-glucuronidase inhibition) is real and demonstrated in one small human pharmacology study, but every cancer-prevention claim rests on rat models from the 1980s–90s — there are no human clinical-outcome trials.
Quick decision guide
May help most
There's no condition with quality human-outcome evidence. People drawn to it are typically motivated by mechanistic 'estrogen recycling' theories that haven't been clinically validated.
Common dosing range
1,500–3,000 mg/day in divided doses (matches the dose used in the Dwivedi pharmacology study).
When to expect effects
Pharmacologic enzyme inhibition within weeks; no clinical endpoint has been demonstrated.
Watch out for
Don't take it as a substitute for evidence-based cancer screening or hormone-related treatment. It may theoretically alter clearance of drugs eliminated via glucuronidation.
Evidence snapshot
What is it
Calcium d-glucarate is the calcium salt of d-glucaric acid, a compound found naturally in fruits and vegetables such as oranges, apples, broccoli, and Brussels sprouts. It is marketed as a supplement primarily for its potential to support estrogen and toxin metabolism via inhibition of beta-glucuronidase.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Beta-glucuronidase inhibition (pharmacologic effect) Limited Evidence | Dose-dependent reduction in serum and gut beta-glucuronidase activity in one small (n=12) human study | None for a clinical purpose; this is a mechanistic finding only | Weeks of regular dosing to see serum enzyme change |
Cancer chemoprevention (animal data only) Mixed Evidence | 25–70% reduction in chemically-induced tumor incidence/multiplicity in rats; no human-outcome data | None — animal-only evidence base | Animal trials measured months of dietary exposure; human equivalent unknown |
Estrogen metabolism / 'detoxification' support Mixed Evidence | No measured estrogen-level changes in any published human trial | None — without measurement of estrogen outcomes, the claim is unsubstantiated | Not established |
Lipid lowering (cholesterol) Mixed Evidence | Not measured in humans | None for this purpose | Not established |
Beta-glucuronidase inhibition (pharmacologic effect)
- Effect
- Dose-dependent reduction in serum and gut beta-glucuronidase activity in one small (n=12) human study
- Best fit
- None for a clinical purpose; this is a mechanistic finding only
- Time
- Weeks of regular dosing to see serum enzyme change
Cancer chemoprevention (animal data only)
- Effect
- 25–70% reduction in chemically-induced tumor incidence/multiplicity in rats; no human-outcome data
- Best fit
- None — animal-only evidence base
- Time
- Animal trials measured months of dietary exposure; human equivalent unknown
Estrogen metabolism / 'detoxification' support
- Effect
- No measured estrogen-level changes in any published human trial
- Best fit
- None — without measurement of estrogen outcomes, the claim is unsubstantiated
- Time
- Not established
Lipid lowering (cholesterol)
- Effect
- Not measured in humans
- Best fit
- None for this purpose
- Time
- Not established
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Beta-glucuronidase inhibition (pharmacologic effect)
Biomarker supportCalcium D-glucarate slowly hydrolyses in the gut to release D-glucaro-1,4-lactone, a competitive inhibitor of bacterial beta-glucuronidase. A 1990 pharmacology study in 12 healthy adults (Dwivedi) showed 3 g/day for 21 days reduced serum beta-glucuronidase activity. This is a real but indirect biomarker — it doesn't tell you whether any clinical outcome changes as a result.
Bottom line: The biochemistry is real. Whether that translates to any clinical benefit is unknown.
Cancer chemoprevention (animal data only)
Mechanism onlyIn rat models, dietary calcium glucarate at 0.5–2% of diet reduced chemically-induced mammary, colon, lung, skin, and liver tumors by roughly 25–70%. The proposed mechanism: beta-glucuronidase inhibition reduces enterohepatic recycling of carcinogens and pro-carcinogens conjugated as glucuronides. There are no human trials. The animal doses, on a body-weight basis, far exceed practical human supplement doses. Don't extrapolate to cancer prevention.
Bottom line: Strong-looking animal data, zero human-outcome trials. Don't bet your cancer-prevention strategy on it.
Estrogen metabolism / 'detoxification' support
Mechanism onlyThe popular claim is that CDG lowers estrogen reabsorption by reducing beta-glucuronidase, thereby treating 'estrogen-dominant' conditions (PMS, fibroids, endometriosis, hormone-driven cancers). The mechanism is biologically plausible — estrogens are excreted as glucuronide conjugates — but no human trial has measured serum or urinary estrogen levels, symptom outcomes, or condition-specific endpoints after CDG supplementation.
Bottom line: Marketing claim that's repeated everywhere; there's no clinical trial behind it.
Lipid lowering (cholesterol)
Mechanism onlySome sources cite CDG for cholesterol reduction. The evidence is limited to one early preclinical study suggesting reduced cholesterol absorption via altered enterohepatic recycling. No human cholesterol trials have been published; the claim has no clinical support.
Bottom line: Skip CDG for cholesterol — multiple proven options exist.
How it works
How to take it
What to track
Bottom line: Take 1,500–3,000 mg/day in divided doses with food if you're trying it on a mechanistic basis. There are no outcome trials to validate any specific result.
2 commercial forms
Compare the main delivery options and what they’re best suited for.
Calcium D-glucarate (CDG)
Standard formThe calcium salt of D-glucaric acid. The only form commonly available as a supplement. Slowly hydrolyses in the gut to release the active D-glucaro-1,4-lactone. All published research uses this salt.
Gradual gut release of the active glucarolactone; the only form with human pharmacology data.
Dietary D-glucaric acid (fruits and vegetables)
Whole-food sourceD-glucaric acid occurs naturally in oranges, apples, grapefruit, cherries, apricots, and cruciferous vegetables. Daily dietary intake is around 5–15 mg of free glucaric acid plus precursors — far below supplement doses. No outcome data either way.
Low dietary doses with the rest of the food matrix; not a substitute for supplement dosing if that's the goal.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Potential alteration of drug elimination: CDG inhibits beta-glucuronidase, which can affect the enterohepatic recycling of drugs excreted as glucuronide conjugates (some opioids, oral contraceptives, lamotrigine, atorvastatin, raloxifene). The clinical magnitude in humans is unstudied.
Hypothetical reduction in contraceptive efficacy: if reduced enterohepatic recycling of estrogen lowers active estrogen exposure, oral contraceptive failure is theoretically possible. No clinical reports, but a known concern often cited.
Who should avoid it
- Women on oral contraceptives — theoretical reduction in contraceptive efficacy; consider non-hormonal contraception or backup method.
- Patients on medications eliminated via glucuronidation (lamotrigine, raloxifene, some opioids, atorvastatin) — discuss with prescriber before adding CDG.
- People with hormone-sensitive cancers using CDG instead of established treatment — there is no evidence it works and avoidance of proven therapy is dangerous.
- Pregnancy and breastfeeding — no safety data; avoid.
Pregnancy & breastfeeding
There are no safety data for CDG in pregnancy or lactation. Avoid in both. D-glucaric acid is present naturally in fruits and vegetables and dietary intake is safe; concentrated supplementation hasn't been studied in these populations.
Bottom line: Generally well tolerated at studied doses. The main concern is the theoretical interaction with drugs cleared via glucuronidation — especially oral contraceptives — and the absence of safety data in pregnancy.
Interactions
Theoretical reduction in contraceptive efficacy via reduced enterohepatic recycling of estrogen. No clinical reports, but the mechanism is plausible and worth a backup non-hormonal method.
Lamotrigine is cleared primarily via glucuronidation; CDG-induced changes in this pathway could theoretically alter levels. No clinical data; cautious co-administration with neurologist guidance.
Raloxifene undergoes extensive enterohepatic recycling involving beta-glucuronidase. CDG could theoretically reduce its effective exposure. No human data.
Theoretical alteration of opioid elimination via beta-glucuronidase modulation. Clinical relevance unknown.
Atorvastatin glucuronides participate in enterohepatic recycling. CDG could theoretically alter exposure, though no clinical data exists.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Oranges, raw | 1 medium (~10 mg D-glucaric acid) | — |
| Grapefruit, raw | ½ medium (~10 mg D-glucaric acid) | — |
| Apples, with skin | 1 medium (~5 mg D-glucaric acid) | — |
| Apricots, raw | 3 medium (~3 mg D-glucaric acid) | — |
| Cherries, sweet | 1 cup (~3 mg D-glucaric acid) | — |
| Broccoli, raw | 1 cup chopped (~4 mg D-glucaric acid) | — |
| Brussels sprouts, raw | 1 cup (~3 mg D-glucaric acid) | — |
| Cabbage, raw | 1 cup shredded (~2 mg D-glucaric acid) | — |
Oranges, raw
- Amount
- 1 medium (~10 mg D-glucaric acid)
- %DV
- —
Grapefruit, raw
- Amount
- ½ medium (~10 mg D-glucaric acid)
- %DV
- —
Apples, with skin
- Amount
- 1 medium (~5 mg D-glucaric acid)
- %DV
- —
Apricots, raw
- Amount
- 3 medium (~3 mg D-glucaric acid)
- %DV
- —
Cherries, sweet
- Amount
- 1 cup (~3 mg D-glucaric acid)
- %DV
- —
Broccoli, raw
- Amount
- 1 cup chopped (~4 mg D-glucaric acid)
- %DV
- —
Brussels sprouts, raw
- Amount
- 1 cup (~3 mg D-glucaric acid)
- %DV
- —
Cabbage, raw
- Amount
- 1 cup shredded (~2 mg D-glucaric acid)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Does calcium d-glucarate lower estrogen?⌄
Mechanistic and small human studies suggest it can increase elimination of estrogen by reducing reabsorption in the gut. Whether this leads to meaningful clinical benefits in hormone balance or cancer prevention is not yet established.
Can it interfere with my birth control?⌄
Possibly, in theory. Oral contraceptive hormones undergo glucuronidation and enterohepatic recirculation, which calcium d-glucarate could disrupt. There are no specific contraceptive failures documented, but caution and clinician input are wise.
Is calcium d-glucarate the same as glucosamine?⌄
No. Calcium d-glucarate is a glucuronidation-related compound. Glucosamine is an amino sugar used for joint health. The names sound similar but they have completely different roles.
How long until I notice anything?⌄
Most users do not feel acute effects since the proposed benefits (altered hormone or toxin metabolism) are not subjectively obvious. Clinical research has typically measured biochemical changes over weeks to months.
Is it safe to take long-term?⌄
Short-term studies show good tolerability. Long-term safety at higher doses is not well-characterized. Most users cycle or use it at modest doses.
References by claim
Beta-glucuronidase inhibition (pharmacologic effect)
Cancer chemoprevention (animal data only)
Estrogen metabolism / 'detoxification' support
Linus Pauling Institute — Micronutrient Information Center — Glucaric Acid (2017) link
Track Calcium d-Glucarate with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.